共 47 条
- [41] RETRACTED: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study (Retracted Article) SUPPORTIVE CARE IN CANCER, 2017, 25 (04) : 1279 - 1289
- [42] Low Non Relapse Mortality and Good Hematological Response after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients with Renal Insufficiency at Transplant: A Prospective Societe Francaise De Greffe De Moelle-Therapie Cellulaire Observational Study BLOOD, 2022, 140 : 7219 - 7221
- [44] Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Societe Francophone de Greffe de Moelle-Therapie Cellulaire observational study BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1450 - 1458
- [45] RETRACTION: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study (Retraction of Vol 25, Pg 1279, 2017) SUPPORTIVE CARE IN CANCER, 2021, 29 (01) : 533 - 534
- [47] Interim PK analysis results of a phase IIa, open-label, randomized, pharmacokinetic comparative, cross-over study of melphalan HCl for injection (propylene glycol-free) and alkeran for injection for myeloablative conditioning in multiple myeloma patients undergoing autologous transplantation JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)